Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
905

Quick answer

905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7709625

    Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy

    The Board of Regents of the University of Texas · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7709517

    Diarylhydantoin compounds

    The Regents of the University of California · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7709643

    Synthesis of sodium narcistatin and related compounds

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7709493

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7709515

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Esperion Therapeutics, Inc. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7709252

    Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7709443

    Cyclic peptide antitumor agents

    Northwestern University · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7709257

    Models for vaccine assessment

    VaxDesign Corp. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7709456

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7708987

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7709007

    Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7709002

    Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7709609

    Tumor suppressor gene, p47ING3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7713710

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7713939

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7713973

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7714088

    Poly(ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7714137

    Pyridyl substituted heterocycles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7714114

    Conjugates of an EPO moiety and a polymer

    Nektar Therapeutics · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7714109

    Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7713995

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7714014

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7714009

    Nitrogen-containing fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7713987

    Pyrimidine-2,4-diamines and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7713983

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7713934

    Thrombin peptide derivatives

    The Board of Regents of the University of Texas System · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7713927

    Antimicrobial peptides

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7713925

    Syndecans and angiogenesis

    Regents of the University of Minnesota · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7713721

    Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7713526

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7713529

    Methods for treating and preventing infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7714007

    Method of alleviating chronic pain via peripheral glutaminase regulation

    The Board of Regents of the University of Oklahoma · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. CA 2742910

    THERAPIE DE COMBINAISON COMPRENANT UN INHIBITEUR DE DHODH ET DU METHOTREXATE POUR TRAITER UNE MALADIE AUTO-IMMUNE

    4SC AG [DE] · Granted Fri May 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu May 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7718779

    Prophylactic and therapeutic monoclonal antibodies

    The United States of America as represented by the Secretary of the Army · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7718629

    Compositions and methods for inhibiting expression of Eg5 gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7718798

    Indole compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7718684

    Methods and materials for assessing prostate cancer therapies and compounds

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7718781

    Hydroxypyridonate and hydroxypyrimidinone chelating agents

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7718618

    Human cathelicidin antimicrobial peptides

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7718658

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7718600

    IAP binding compounds

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7718428

    Myeloid colony stimulating factor and uses thereof

    HALOZYME, INC. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7718424

    AAV4 vector and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7718386

    Methods for the diagnosis of diabetes

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7718183

    Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7718170

    Alkaline phosphatase compositions to reduce skin cancer

    Essential Skincare, LLC · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

905 published patents in our USPTO index have expiration dates falling in calendar year 2030.